Aurora Cannabis (TSXV:ACB,CSE:ACB,FWB:21P,OTCQB:ACBFF) has commenced trading on the TSX-V under the symbol ACB.
As quoted in the press release:
Aurora’s move from the CSE to the TSX-V follows a year of significant achievements for the Company. These include receipt of its license from Health Canada to sell dried cannabis, commencement of commercial operations, brisk market penetration and sales growth, multiple financings, and the announcement of a material expansion plan. Aurora has been one of the most actively traded stocks on the CSE over the past two months, providing significant liquidity and enhanced value for its investors and positioning the Company extremely well to remain a market leader on the TSX-V.
“Listing on the TSX-V is an important milestone in our development, reflecting the remarkably rapid operational and commercial progress Aurora has made this year,” said Terry Booth, CEO of Aurora. “Visibility of the Company has increased significantly as a result of our recent financings, our industry leading patient registration rate, our strategic acquisition of CanvasRx, and the announcement of our plans to expand production capacity to more than 70,000 kg per year.”
“We believe that trading on the TSX-V will enable us to engage and satisfy an even wider investor audience,” added Mr. Booth. “Aurora continues to set new standards in the industry, and we are focused strongly on further building shareholder value. We will continue the disciplined execution of our business strategy to solidify and expand our leadership position in the cannabis sector. We look forward to reporting on our progress as a more visible member of the community of listed companies.”